Anti-CD20 Monoclonal Antibodies

Monoclonal antibodies targeting CD20 on B cells. Used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and multiple sclerosis.

HCPCS J-codes in this class (4)

Code	Description	Status
J2350	Injection, ocrelizumab, 1 mg	active
J9301	Obinutuzumab inj	active
J9311	Inj rituximab, hyaluronidase	active
J9312	Inj., rituximab, 10 mg	active